Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPR Induction in Elderly Newly Diagnosed Multiple Myeloma
NCT00396045Phase 2Completed
- Sponsor
- University of Turin
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in multiple myeloma (MM), sponsored by University of Turin. Started Jan 2005; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00396045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00396045.